These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5718434)

  • 41. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
    Frey AB
    J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance to transplants of recent spontaneous parental line tumors by F1 hybrid hosts.
    Sanford BH; Soo SF
    J Natl Cancer Inst; 1971 Jan; 46(1):95-101. PubMed ID: 4993665
    [No Abstract]   [Full Text] [Related]  

  • 44. Biochemical evidence for expression of a semi-allogeneic, H-2 antigen by a murine adenocarcinoma.
    Callahan GN; Pardi D; Giedlin MA; Allison JP; Morizot DM; Martin WJ
    J Immunol; 1983 Jan; 130(1):471-9. PubMed ID: 6847892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.
    Carr-Brendel V; Markovic D; Ferrer K; Smith M; Taylor-Papadimitriou J; Cohen EP
    Cancer Res; 2000 May; 60(9):2435-43. PubMed ID: 10811121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electron microscope observations on virus particles associated with a transplantable renal adenocarcinoma in BALB-cf-Cd mice.
    Felluga B; Claude A; Mrena E
    J Natl Cancer Inst; 1969 Aug; 43(2):319-33. PubMed ID: 5797837
    [No Abstract]   [Full Text] [Related]  

  • 47. Subcellular fractions from spleen and liver as transplantation antigens in various genetic differences.
    Sankowski A; Skopińska E; Nouza K
    Folia Biol (Praha); 1968; 14(5):405-8. PubMed ID: 5725519
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunogenic enhancement by neuraminidase.
    Oxley S; Griffen WO
    Surg Forum; 1971; 22():113-4. PubMed ID: 5121313
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S; Ritter F; Becker S
    J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
    [No Abstract]   [Full Text] [Related]  

  • 50. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.
    Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM
    Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A long-term memory obtained by genetic immunization results in full protection from a mammary adenocarcinoma expressing an EBV gene.
    Charo J; Ciupitu AM; Le Chevalier De Préville A; Trivedi P; Klein G; Hinkula J; Kiessling R
    J Immunol; 1999 Dec; 163(11):5913-9. PubMed ID: 10570277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interacting influences of embryonic & neoplastic systems. I. Responses in chick embryo to the grafted mouse mammary adenocarcinoma.
    Palayoor ST; Batra BK
    Indian J Exp Biol; 1971 Jul; 9(3):300-3. PubMed ID: 4401340
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of tumor immunity after complete excision, cryonecrosis, and in the presence of persistent tumor.
    Neel HB; Ketcham AS; Hammond WG
    Surg Forum; 1970; 21():120-2. PubMed ID: 5514704
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of dietary amino acids on tumour growth and cell-mediated immune responses.
    Bounous G; Sadarangani C; Pang KC; Kongshavn PA
    Clin Invest Med; 1981; 4(2):109-15. PubMed ID: 7026098
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma.
    Dorsey R; Kundu N; Yang Q; Tannenbaum CS; Sun H; Hamilton TA; Fulton AM
    Cancer Res; 2002 May; 62(9):2606-10. PubMed ID: 11980656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperbaric pressure effects measured by growth of a transplantable tumor in the C3H/HeN mouse.
    Herndon BL; Lally JJ
    J Natl Cancer Inst; 1984 Sep; 73(3):679-87. PubMed ID: 6590914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The activity of cell-free tumour fractions in inducing immunity across a weak histocompatibility barrier.
    Wolf A
    Transplantation; 1969 Jan; 7(1):49-58. PubMed ID: 5762195
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.
    Allione A; Consalvo M; Nanni P; Lollini PL; Cavallo F; Giovarelli M; Forni M; Gulino A; Colombo MP; Dellabona P
    Cancer Res; 1994 Dec; 54(23):6022-6. PubMed ID: 7954438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.